Lexicon Pharmaceuticals, Inc. SEC filings LXRX
Lexicon Pharmaceuticals, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Jan 8, 2010. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 2, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 2, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 4, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 3, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 5, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 9, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 6, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Oct 30, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Jul 29, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | Apr 27, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Nov 7, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 1, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 1, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Nov 1, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Jul 30, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 3, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Nov 8, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 1, 2017 | Jun 30, 2017 |
| 10-Q/A | Amended quarterly report | Aug 1, 2017 | Aug 1, 2017 |
| 10-Q | Quarterly report | May 4, 2017 | Mar 31, 2017 |
| 10-Q | Quarterly report | Nov 7, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Aug 4, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | May 5, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | Nov 9, 2015 | Sep 30, 2015 |
| 10-Q | Quarterly report | Aug 7, 2015 | Jun 30, 2015 |
| 10-Q | Quarterly report | May 5, 2015 | Mar 31, 2015 |
| 10-Q/A | Amended quarterly report | Dec 23, 2014 | Dec 23, 2014 |
| 10-Q | Quarterly report | Nov 6, 2014 | Sep 30, 2014 |
| 10-Q | Quarterly report | Aug 7, 2014 | Jun 30, 2014 |
| 10-Q | Quarterly report | May 8, 2014 | Mar 31, 2014 |
| 10-Q | Quarterly report | Nov 12, 2013 | Sep 30, 2013 |
| 10-Q | Quarterly report | Aug 1, 2013 | Jun 30, 2013 |
| 10-Q | Quarterly report | May 10, 2013 | Mar 31, 2013 |
| 10-Q | Quarterly report | Nov 7, 2012 | Sep 30, 2012 |
| 10-Q | Quarterly report | Aug 2, 2012 | Jun 30, 2012 |
| 10-Q | Quarterly report | May 3, 2012 | Mar 31, 2012 |
| 10-Q | Quarterly report | Nov 1, 2011 | Sep 30, 2011 |
| 10-Q | Quarterly report | Aug 9, 2011 | Jun 30, 2011 |
| 10-Q | Quarterly report | May 5, 2011 | Mar 31, 2011 |
| 10-Q | Quarterly report | Nov 8, 2010 | Sep 30, 2010 |
| 10-Q | Quarterly report | Aug 9, 2010 | Jun 30, 2010 |
| 10-Q | Quarterly report | May 10, 2010 | Mar 31, 2010 |
Showing 53 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LXRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- The Woodlands, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1062822
- Former names
- LEXICON PHARMACEUTICALS, INC./DE (until Dec 5, 2014); LEXICON GENETICS INC/TX (until Apr 2, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.